Simon Raffel
Ruprecht-Karls-Universität Heidelberg
H-index: 18
Europe-Germany
Top articles of Simon Raffel
A specific ribomethylome pattern in lung cancer is associated with increased risk of metastasis
Cancer Research
2024/3/22
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis
Blood Journal
2024/3/22
Inotuzumab ozogamicin as induction therapy for patients older than 55 years with Philadelphia chromosome–negative B-precursor ALL
Journal of Clinical Oncology
2024/1/20
Simon Raffel
H-Index: 12
Somatic epimutations enable single-cell lineage tracing in native hematopoiesis across the murine and human lifespan
bioRxiv
2024
Indranil Singh
H-Index: 2
Simon Raffel
H-Index: 12
Venetoclax and Blinatumomab for Adult Patients with Relapsed/Refractory or MRD Positive Ph-Negative B-Precursor ALL: First Results of the GMALL-Bliven Trial
Blood
2023/11/28
P438: INTRACELLULAR CITRATE LEVELS MODULATE ANTI-APOPTOTIC PROTEINS TO ENHANCE VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKEMIA STEM CELLS
HemaSphere
2023/8/1
P408: COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
HemaSphere
2023/8/1
Maike Janssen
H-Index: 1
Simon Raffel
H-Index: 12
PB1790: LOOKING ‘BENEATH’THE SURFACE: PROTEOMICS AND GLYCIPROTEOMICS REVEAL NOVEL TARGETS FOR CAR-T CELL THERAPIES IN ACUTE MYELOID LEUKEMIA (AML)
HemaSphere
2023/8/1
P470: SINGLE-CELL METABOLIC MULTIOMICS TO IDENTIFY VULNERABILITIES IN ACUTE MYELOID LEUKEMIA STEM CELLS
HemaSphere
2023/8/1
Simon Raffel
H-Index: 12
P323: UNCOVERING SUBCLONAL METABOLIC VULNERABILITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA AT SINGLE CELL RESOLUTION
HemaSphere
2023/8/1
Simon Raffel
H-Index: 12
S114: OUTCOME OF OLDER PATIENTS (> 55 YRS) WITH NEWLY DIAGNOSED PH/BCR: ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
HemaSphere
2023/8/1
Simon Raffel
H-Index: 12
The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia
Leukemia
2023/8
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
Haematologica
2023/7/7
Michael Stadler
H-Index: 8
Simon Raffel
H-Index: 12
Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to azacitidine/venetoclax
Cancer discovery
2023/6/2
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia
Cell Stem Cell
2023/5/4
CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis
Cancer Research
2023/4/4
Jean-Pierre Bourquin
H-Index: 36
Simon Raffel
H-Index: 12
Methods for sub-typing and treating cancer
2023/2/28
A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia
Cancer discovery
2023/2/6
Yi Liu
H-Index: 21
Christian Rohde
H-Index: 16
Haiyang Yun
H-Index: 1
Christoph Röllig
H-Index: 32
Simon Raffel
H-Index: 12
Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
bioRxiv
2023
Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with Ph/BCR:: ABL Negative B-Precursor Adult Lymphoblastic Leukemia (ALL …
Blood
2023/11/28
Simon Raffel
H-Index: 12
